Literature DB >> 27234146

Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4).

Rocco D Gogliotti1, Anna L Blobaum1, Ryan M Morrison1, J Scott Daniels1, James M Salovich1, Yiu-Yin Cheung1, Alice L Rodriguez1, Matthew T Loch1, P Jeffrey Conn2, Craig W Lindsley3, Colleen M Niswender2, Corey R Hopkins4.   

Abstract

Herein we report the synthesis and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as novel positive allosteric modulators of mGlu4. We detail our work towards finding phenyl replacements for the core scaffold of previously reported phenyl sulfonamides and phenyl sulfone compounds. Our efforts culminated in the identification of N-(1-((3,4-dimethylphenyl)sulfonyl)-1H-pyrrol-3-yl)picolinamide as a potent PAM of mGlu4.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Metabotropic glutamate receptor 4; PK; Phenyl replacement; Positive allosteric modulator (PAM); Pyrrole sulfonamide

Mesh:

Substances:

Year:  2016        PMID: 27234146      PMCID: PMC4955388          DOI: 10.1016/j.bmcl.2016.05.029

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  24 in total

Review 1.  Recent progress in the development of mGluR4 positive allosteric modulators for the treatment of Parkinson's disease.

Authors:  Craig W Lindsley; Colleen M Niswender; Darren W Engers; Corey R Hopkins
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 2.  Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeutics.

Authors:  Albert J Robichaud; Darren W Engers; Craig W Lindsley; Corey R Hopkins
Journal:  ACS Chem Neurosci       Date:  2011-06-14       Impact factor: 4.418

Review 3.  Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.

Authors:  Chad J Swanson; Mark Bures; Michael P Johnson; Anni-Maija Linden; James A Monn; Darryle D Schoepp
Journal:  Nat Rev Drug Discov       Date:  2005-02       Impact factor: 84.694

4.  The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.

Authors:  Carrie K Jones; Michael Bubser; Analisa D Thompson; Jonathan W Dickerson; Nathalie Turle-Lorenzo; Marianne Amalric; Anna L Blobaum; Thomas M Bridges; Ryan D Morrison; Satyawan Jadhav; Darren W Engers; Kimberly Italiano; Jacob Bode; J Scott Daniels; Craig W Lindsley; Corey R Hopkins; P Jeffrey Conn; Colleen M Niswender
Journal:  J Pharmacol Exp Ther       Date:  2011-11-16       Impact factor: 4.030

5.  A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease.

Authors:  Emmanuel Le Poul; Christelle Boléa; Francoise Girard; Sonia Poli; Delphine Charvin; Brice Campo; Julien Bortoli; Abdhelak Bessif; Bin Luo; Amy Jo Koser; Lisa M Hodge; Karen M Smith; Anthony G DiLella; Nigel Liverton; Fred Hess; Susan E Browne; Ian J Reynolds
Journal:  J Pharmacol Exp Ther       Date:  2012-07-11       Impact factor: 4.030

6.  Solution-phase parallel synthesis and SAR of homopiperazinyl analogs as positive allosteric modulators of mGlu₄.

Authors:  Yiu-Yin Cheung; Rocio Zamorano; Anna L Blobaum; C David Weaver; P Jeffrey Conn; Craig W Lindsley; Colleen M Niswender; Corey R Hopkins
Journal:  ACS Comb Sci       Date:  2011-02-21       Impact factor: 3.784

7.  Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats.

Authors:  Darren W Engers; Julie R Field; Uyen Le; Ya Zhou; Julie D Bolinger; Rocio Zamorano; Anna L Blobaum; Carrie K Jones; Satyawan Jadhav; C David Weaver; P Jeffrey Conn; Craig W Lindsley; Colleen M Niswender; Corey R Hopkins
Journal:  J Med Chem       Date:  2011-01-19       Impact factor: 7.446

8.  Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS).

Authors:  Darren W Engers; Patrick R Gentry; Richard Williams; Julie D Bolinger; C David Weaver; Usha N Menon; P Jeffrey Conn; Craig W Lindsley; Colleen M Niswender; Corey R Hopkins
Journal:  Bioorg Med Chem Lett       Date:  2010-07-08       Impact factor: 2.823

Review 9.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

10.  Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4).

Authors:  Darren W Engers; Anna L Blobaum; Rocco D Gogliotti; Yiu-Yin Cheung; James M Salovich; Pedro M Garcia-Barrantes; J Scott Daniels; Ryan Morrison; Carrie K Jones; Matthew G Soars; Xiaoliang Zhuo; Jeremy Hurley; John E Macor; Joanne J Bronson; P Jeffrey Conn; Craig W Lindsley; Colleen M Niswender; Corey R Hopkins
Journal:  ACS Chem Neurosci       Date:  2016-05-03       Impact factor: 4.418

View more
  2 in total

Review 1.  Recent advances in the medicinal chemistry of group II and group III mGlu receptors.

Authors:  Chaobin Jin; Shutao Ma
Journal:  Medchemcomm       Date:  2017-01-13       Impact factor: 3.597

Review 2.  N-Pyrrylarylsulfones with High Therapeutic Potential.

Authors:  Valeria Famiglini; Sabrina Castellano; Romano Silvestri
Journal:  Molecules       Date:  2017-03-09       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.